Bernd R. Seizinger insider trades

Open-market stock purchases and sales by Bernd R. Seizinger, Director at Aprea Therapeutics, Inc, from SEC Form 4 filings since Oct 7, 2019.

Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -42%.

Recent trades

DateStockTradeValue
Jun 16, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Jun 16, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Jun 1, 2026ONCY Oncolytics Biotech IncBought (not open market)—
Feb 12, 2026ONCY Oncolytics Biotech IncBought$33.9K
Feb 11, 2026ONCY Oncolytics Biotech IncBought$49.6K
Jan 16, 2026ONCY Oncolytics Biotech IncBought$104K

Companies traded

  • APRE Aprea Therapeutics, Inc: 6 buys, last Jun 16, 2026
  • ONCY Oncolytics Biotech Inc: 3 buys, last Jun 1, 2026
  • APTO Aptose Biosciences Inc: 1 buy, last Feb 5, 2024

Get free alerts when Bernd R. Seizinger files a new trade →